FLT190 Granted Orphan Drug Status in Europe as Potential Gene Therapy for Fabry Disease
The gene therapy candidate FLT190 — designed to increase blood levels of the enzyme alpha-GAL A, which is affected in Fabry disease — has been granted orphan drug designation by the European Commission,…